News
Recursion strengthened its AI focus by snapping up two companies in the AI-driven drug discovery space.
Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. Quiver AI Summary MIT and Recursion have released Boltz-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback